Innate Pharma SA (IPHA) Form 6-K — Oct 20, 2026
Innate Pharma SA announced it will hold a conference call on Thursday, November 5, 2026, at 2 p.m. CET / 8 a.m. ET to provide a business and financial update for the third quarter of 2026. The call will feature CEO Jonathan Dickinson, CMO Markus Jensen, COO Yannis Morel, CFO Frédéric Lombard, and IR head Stéphanie Cornen.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.